Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celgene-CELG -- Ignore unavailable to you. Want to Upgrade?

To: Mike K who wrote (544)	6/21/2001 8:39:27 PM
From: jayhawk969	Read Replies (1) \| Respond to of 804

Wishing you the very best, and I pray that this line of defense works for you.

To: Mike K who wrote (544)	6/21/2001 9:00:05 PM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 804

Mike, I am glad that T work well for you. I am T believer. However, T is very complex (multiple metabolites) and still not fully understood. Sometimes does reduce toxicity of the chemo, sometimes increase toxicity. What oncologist needs are clear picture where and when T is dangerous, and where does help the best. Based on recent good news from T clinical data one will expect further market penetration. However, current picture is bit different. I would like to know why are oncologists afraid? Miljenko